Viewing Study NCT03712605


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2025-12-26 @ 1:52 AM
Study NCT ID: NCT03712605
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2018-10-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module